Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

Chia Siang Kow; Long Chiau Ming; Syed Shahzad Hasan

doi:10.1038/s41440-021-00670-w

Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

Chia Siang Kow, Long Chiau Ming, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1042-1045
Number of pages	4
Journal	Hypertension Research
Volume	44
Issue number	8
Early online date	20 May 2021
DOIs	https://doi.org/10.1038/s41440-021-00670-w
Publication status	Published - 1 Aug 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41440-021-00670-wLicence: Unspecified

Cite this

@article{b1e33aa4210c42eb8c6ca87757048f37,

title = "Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials",

keywords = "COVID-19, SARS-CoV-2, randomised control trial, angiotensin-converting enzyme, ACE, ACE inhibitors, angiotensin receptor blocker, ARB, renin–angiotensin-system, RAS inhibitor, renin–angiotensin–aldosterone, RAA inhibitor, RAAS inhibitor",

author = "Kow, \{Chia Siang\} and Ming, \{Long Chiau\} and Hasan, \{Syed Shahzad\}",

year = "2021",

month = aug,

day = "1",

doi = "10.1038/s41440-021-00670-w",

language = "English",

volume = "44",

pages = "1042--1045",

journal = "Hypertension Research",

issn = "0916-9636",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19

T2 - a meta-analysis of randomized controlled trials

AU - Kow, Chia Siang

AU - Ming, Long Chiau

AU - Hasan, Syed Shahzad

PY - 2021/8/1

Y1 - 2021/8/1

KW - COVID-19

KW - SARS-CoV-2

KW - randomised control trial

KW - angiotensin-converting enzyme

KW - ACE

KW - ACE inhibitors

KW - angiotensin receptor blocker

KW - ARB

KW - renin–angiotensin-system

KW - RAS inhibitor

KW - renin–angiotensin–aldosterone

KW - RAA inhibitor

KW - RAAS inhibitor

UR - https://www.scopus.com/pages/publications/85106300852

U2 - 10.1038/s41440-021-00670-w

DO - 10.1038/s41440-021-00670-w

M3 - Letter

C2 - 34017093

SN - 0916-9636

VL - 44

SP - 1042

EP - 1045

JO - Hypertension Research

JF - Hypertension Research

IS - 8

ER -

Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

UN SDGs

Access to Document

Other files and links

Cite this